Physician profile
Daniel G Kolder
NPI 1942393053
$5,674.10
in general payments reported to CMS, 2019-2025
16 companies · $1,092 in 2025
The $1,092 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,137 · 2020: $136 · 2021: $174 · 2022: $370 · 2023: $388 · 2024: $378 · 2025: $1,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $769 · Education: $25.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $769.25 |
| Education | $25.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,329.66 | 2019-2022 | |
| Abbvie INC. | $1,115.19 | 2023-2025 | |
| Tepha INC | $254.80 | 2019-2020 | |
| Merz North America, INC. | $207.52 | 2022 | |
| Genzyme Corporation | $163.94 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $141.74 | 2024-2025 | Dupixent |
| Incyte Corporation | $117.99 | 2024-2025 | Opzelura |
| Janssen Biotech, INC. | $69.11 | 2024-2025 | Tremfya |
| Lilly USA, LLC | $57.37 | 2025 | Taltz, Ebglyss |
| Organon LLC | $49.44 | 2025 | |
| Sun Pharmaceutical Industries INC. | $49.14 | 2024-2025 | |
| Smith+Nephew, INC. | $39.02 | 2025 | Grafix Pl |
| Sientra, INC. | $23.99 | 2020 | |
| Galderma Laboratories, L.P. | $20.29 | 2025 | Dysport |
| Leo Pharma INC. | $18.60 | 2025 | Anzupgo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $16.30 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kolder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.